Author:
Patton Monica E.,Stephens David,Moore Kelly,MacNeil Jessica R.
Publisher
Centers for Disease Control MMWR Office
Subject
Health Information Management,Health, Toxicology and Mutagenesis,General Medicine,Health(social science),Epidemiology
Reference13 articles.
1. Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal disease.;McNeil;Microbiol Mol Biol Rev,2013
2. The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens.;Serruto;Vaccine,2012
3. Use of serogroup B meningococcal vaccines in persons aged ≥10 years at increased risk for serogroup B meningococcal disease: recommendations of the Advisory Committee on Immunization Practices, 2015.;Folaranmi;MMWR Morb Mortal Wkly Rep,2015
4. Use of serogroup B meningococcal vaccines in adolescents and young adults: recommendations of the Advisory Committee on Immunization Practices, 2015.;MacNeil;MMWR Morb Mortal Wkly Rep,2015
5. Food and Drug Administration. Summary basis for regulatory action. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2016. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM496484.pdf
Cited by
90 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献